Home / Newsroom
Keep up to date with the latest developments at CDISC and follow our news feeds!
10 Apr 2017

CDISC Contact:

Andrea Vadakin

+1.316.558.016

Austin, TX – 10 April 2017 – The Clinical Data Interchange Standards Consortium (CDISC) announced that David R. Bobbitt, MSc, MBA will join CDISC as its new Chief Executive Officer today. Mr. Bobbitt succeeds Dr. Rebecca Daniels Kush, CDISC Founder, who completed her 20-year tenure as CDISC President this month. 

30 Mar 2017

CDISC Contact:

Andrea Vadakin

+1.316.558.0160

 

 

Austin, TX – 30 March 2017 – The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the participation of high-level representatives from the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), the Japan Pharmaceuticals and Medical Devices Agency (PMDA), and the Infectious Diseases Data Observatory (IDDO) at the 2017 CDISC Europe Interchange. Participating global regulators will provide discussion around regulatory requirements for use of the CDISC standards that went into effect at the end of last year. Also participating in the conference will be CDISC experts and innovators from industry and academia. This educational and networking conference will be held 24-28 April in London, England.

28 Mar 2017

       

WWARN.png

   

CDISC Contact:

Andrea Vadakin

+1.316.558.0160

   

WWARN Contact:

Anne Whitehouse

+44 (0)1865 612948

 

23 Mar 2017

Austin, TX – 23 March 2017 – The Clinical Data Interchange Standards Consortium (CDISC) and the Infectious Diseases Data Observatory (IDDO) announce the availability of a new standard to assist in the collection, aggregation and analysis of Ebola virus disease (EVD) research data. This standard is for use in EVD trials, leading to potential treatments and public health surveillance for this disease.

20 Mar 2017

Austin, TX20 March 2017– The Clinical Data Interchange Standards Consortium (CDISC) today announced the addition of three new members to its Board of Directors. Mr. Dave Evans, Dr. Masanori Fukushima, and Mr. Steve Rosenberg have each begun serving a three-year term.

26 Feb 2017 | Leslie Linthicum | Mirage Magazine, a publication of the University of New Mexico Alumni Association

1 Dec 2016 | Barrie Nelson, VP, Standards, Terminology, and Technical Services, CDISC | Applied Clinical Trials

12 Jan 2017 | Sam Hume, Head of Data Technologies | Applied Clinical Trials

30 Nov 2016

Austin, TX – 30 November 2016 – The Clinical Data Interchange Standards Consortium (CDISC) would like to remind the clinical research community that the FDA Binding Guidance goes into effect next month. Sponsors whose studies start after December 17, 2016 must submit data in FDA-supported formats listed in the FDA Data Standards Catalog. The current FDA Data Standards Catalog specifies the use of CDISC standards:  SDTM, SEND, ADaM and Define-XML as well as Controlled Terminology.

15 Nov 2016

Austin, TX – 14  November  2016 – The Clinical Data Interchange Standards Consortium (CDISC) announced today the open availability of a new clinical research data standard for Rheumatoid Arthritis (RA). The RA data standard and accompanying User Guide describe the most common biomedical concepts gathered from patient data relevant to clinical RA studies and defines concepts in a clear, unambiguous way, allowing researchers to effectively collect, manage, share and compare data to advance treatments and find breakthroughs.